Skip to content

Main Navigation

Vor Bio
  • News & Media
  • Publications
  • Join Us
  • Contact
  • Blog
  • Search
  • About Us
    • Overview
    • Vision, Mission, and Values
    • Our People
    • Leadership
    • Board of Directors
    • Scientific & Clinical Advisors
    • Founding Story
  • Approach
    • Overview
    • The Opportunity
    • The Concept
    • The Science
    • Programs
    • Manufacturing
    • Partnerships
  • Platform & Pipeline
    • Overview
    • Our Platform
    • Our Pipeline
  • Patients & Caregivers
    • Overview
    • Our Investigational Treatment Approach
    • Clinical Trials
    • The Patient/Donor Journey
    • Patient Advocacy
  • Medical Professionals
    • Overview
    • Our Investigational Programs
    • Clinical Trials
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Contact IR
    • Email Alerts

Business First AM: Biotech Trial For AML Treatment

September 14, 2022 by Jake Robison
Bfam Logo

Share This Post

Recent Posts

  • From Concept to Clinical Trial Results: A Conversation with Glen Raffel, MD, PhD, VP of Clinical Research & Development September 21, 2023
  • Reflections of a Vor Bio Scientist August 31, 2023
  • Caring for AML Patients: A Clinical Trial Nurse’s Experience April 24, 2023
  • A Conversation with a First-Generation Woman in STEM: International Day of Women & Girls in Science February 10, 2023
  • How our unwavering focus on patients helped us weather a tough 2022 for biotech December 28, 2022
  • My journey giving a gift of hope by donating bone marrow December 20, 2022
  • This Thanksgiving and every day, take stock of everything you are grateful for November 23, 2022
  • Teamwork on full display during our clinical manufacturing facility buildout November 9, 2022
  • Lending a Hand, Stepping Up for the Larger Community October 4, 2022
Logo Vor Biopharma White

Follow us on social media:

Twitter LinkedIn

Acbj 0234431 Badge Final

Read more about
working at Vor Bio

  • About Us
    • Vision, Mission, and Values
    • Our People
    • Leadership
    • Board of Directors
    • Scientific & Clinical Advisors
    • Founding Story
  • Approach
    • The Opportunity
    • The Concept
    • The Science
    • Programs
    • Manufacturing
    • Partnerships
  • Platform & Pipeline
    • Our Platform
    • Our Pipeline
  • Patients & Caregivers
    • Our Investigational Treatment Approach
    • Clinical Trials
    • The Patient/Donor Journey
    • Patient Advocacy
  • Medical Professionals
    • Our Investigational Programs
    • Clinical Trials
  • Investors
    • News Releases
    • Events & Presentations
    • Analyst Coverage
    • Corporate Governance
    • SEC Filings
    • Contact IR
    • Email Alerts
  • News & Media
  • Publications
  • Join Us
  • Blog

© 2023 Vor Biopharma

  • Privacy Policy
  • Terms of Use
Recruiting Guidelines

All employment opportunities at Vor Biopharma are managed by our in-house Human Resources Department. Therefore, agency staff and independent recruiters must contact the Human Resources Department directly in order to present candidates or inquire about openings. Please do not contact other Vor Bipharma employees. Your ability to comply with this request will significantly impact any decision we may make about doing business with you.

Please understand that we do not accept unsolicited resumes from any source other than from the candidates themselves. Any agency or independent recruiter must have a signed copy of our agency agreement before presenting candidates. Submission of unsolicited resumes without our signed agreement will not create any implied obligation on our part.

If you wish to be considered for the presentation of candidates, please contact us through careers@vorbio.com. Attach your contact information, your area of specialty, and any marketing information you wish to provide. Someone from the Human Resources Department will contact you directly if there is a business need for your services.